InvestorsHub Logo
Followers 22
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: TheFinalCD post# 138098

Tuesday, 05/26/2020 7:17:27 AM

Tuesday, May 26, 2020 7:17:27 AM

Post# of 182977
KTOV
We are glad to announce U.S. FDA IND acceptance to conduct a phase 1/2 clinical trial of NT-219 for treatment of recurrent or metastatic solid tumors and head and neck cancer.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.